dc.contributor.author | Majlessi, Laleh | - |
dc.contributor.author | Charneau, Pierre | - |
dc.date.accessioned | 2022-10-17T15:09:10Z | |
dc.date.available | 2022-10-17T15:09:10Z | |
dc.date.issued | 2021 | |
dc.identifier.citation | Majlessi, Laleh ; Charneau, Pierre ; Un candidat vaccin lentiviral anti-Covid-19 administrable par voie intranasale, Med Sci (Paris), Vol. 37, N° 12 ; p. 1172-1175 ; DOI : 10.1051/medsci/2021173 | |
dc.identifier.issn | 1958-5381 | |
dc.identifier.uri | http://hdl.handle.net/10608/11961 | |
dc.language.iso | fr | |
dc.publisher | EDP Sciences | |
dc.relation.ispartof | Le Magazine | |
dc.rights | Article en libre accès - License CC BY 4.0 | fr |
dc.rights | Médecine/Sciences - Inserm - SRMS | fr |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0 | |
dc.source | M/S. Médecine sciences [ISSN papier : 0767-0974 ; ISSN numérique : 1958-5381], Vol. 37, N° 12; p. 1172-1175 | |
dc.subject.mesh | Administration par voie nasale | fr |
dc.subject.mesh | Vaccins contre la COVID-19 | fr |
dc.subject.mesh | Humains | fr |
dc.subject.mesh | administration et posologie | fr |
dc.title | Un candidat vaccin lentiviral anti-Covid-19 administrable par voie intranasale | fr |
dc.title.alternative | An anti-Covid-19 lentiviral vaccine candidate that can be administered by the nasal route | en |
dc.type | Article | |
dc.contributor.affiliation | Laboratoire Commun Pasteur-TheraVectys, Institut Pasteur , 28 rue du Docteur Roux , 75015 Paris , France | |
dc.identifier.doi | 10.1051/medsci/2021173 | |
dc.identifier.pmid | 34928223 | |